Given the pivotal role of ACMSD in regulating ferroptosis and alleviating AKI, we hypothesized that the targeted knockdown of ACMSD expression in vivo may offer a promising strategy for AKI therapy. The gene discussed is ACMSD; the disease is acute kidney injury.